Abiomed’s $18 Billion Merger Agreement with Johnson & Johnson

Sullivan & Cromwell advised Abiomed on the deal, while Cravath represented Johnson & Johnson. Davis Polk advised J.P. Morgan Securities LLC as financial adviser to Johnson…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here